Advertisement

Topics

Search Results for "Arbonne Annual Revenue 2012"

13:01 EDT 24th April 2017 | BioPortfolio

Matching Channels

macitentan

Macitentan (Opsumit®) is a novel dual endothelin receptor antagonist (ERA) that resulted from a tailored drug discovery process with the target to develop an ERA optimized for efficacy and safet...

Medtronic

With annual sales reaching $15 billion in 2010, Medtronic is the 4th largest medical devices company in the world (based on annual sales). The device portfolio of Medtronic is broad; covering card...

ATX-MS-1467 for patients with multiple sclerosis (MS)

ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the ...

Rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic systemic disease characterized by progressive joint deformity and joint destruction driven by synovial inflammation and hyperplasia in which cytokines play cen...

GE Healthcare

Ranked as the third largest medical device company in the world (based on annual sales), GE Healthcare generates $16 billion in sales each year. GEs' area of expertise is the imaging that is i...

Matching News

Pharma's non-adherence problem is growing

An updated report pegs total global revenue loss at an incredible $637 billion, up nearly 13% from 2012. 

Cynosure Achieves Record Quarterly Revenue of $122. ...

Full-Year 2016 Highlights: Record annual revenue of $433.5 million, up 28 percent year-over-year GAAP earnings of $0.65per diluted share includes $7.2 millioncharge Read more...

Mallinckrodt revenue boosted by higher volumes

Other players in the pharmaceutical industry have recently raised questions about how long hefty annual price-hikes for drugs will continue. Mallinckrodt said its generics segment posted a 19% revenue...

Vertex Pharmaceuticals revenue outlook for cystic fibrosis treatments

Jan 8 Vertex Pharmaceuticals Inc said on Sunday that it expected full-year 2017 revenue from its Orkambi cystic fibrosis treatment of $1.1 billion to $1.3 billion and revenue from its Kalydeco treatme...

Octapharma AG Publishes 2016 Annual Results Reporting Revenue Of ???1.6 Billion And Operating Income Of ???383 Million

  Life Sciences Jobs   ...

Carl Zeiss reports €1.09 billion in annual revenue

Carl Zeiss Meditec posted €1.09 billion in revenue in the 2015-2016 fiscal year, an increase of 4.6% from 2014-2015, the company announced in a press release. Earnings before interest and taxes rose...

Teva drugs help boost Mayne revenue

The $US652 million acquisition of a suite of generic drugs from Teva Pharmaceutical Industries has helped Mayne Pharma to a strong start to the financial year. Mayne Pharma chief executive Scott Richa...

Virbac: annual sales growth of 4.5%, at constant exchange rates

Virbac: annual sales growth of 4.5%, at constant exchange rates Public release - January 17th, 2017 Virbac consolidated revenue in the fourth quarter reached 225.7 M€, a significant +9.2% growth c.....

Matching PubMed Articles

National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA.

Several studies revealed the epidemiology of Kawasaki disease-related hospitalizations among children in the USA and other countries. However, disparities of developing coronary artery aneurysms by ra...

The fourth annual meeting of the American College of Professional Neuropsychology (ACPN) poster roster, March 9-10, 2012, Las Vegas, Nevada.

Publication Rates of Abstracts Accepted to the 2010-2012 Annual Meetings of the North American Spine Society.

Retrospective review of conference abstracts.

Biohydrogen production from waste bread in a continuous stirred tank reactor: A techno-economic analysis.

Biohydrogen production from waste bread in a continuous stirred tank reactor (CSTR) was techno-economically assessed. The treating capacity of the H2-producing plant was assumed to be 2 ton waste brea...

Spatial-Temporal Analysis of Air Pollution, Climate Change, and Total Mortality in 120 Cities of China, 2012-2013.

China has had a rapid increase in its economy over the past three decades. However, the economic boom came at a certain cost of depleting air quality. In the study, we aimed to examine the burden of a...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement